๐ฌ Current Disease Focus:
Task Progress: 0%
๐ฅ Active Problem Solvers
0
๐ Experts collaborating globally
โก Current Task Assignment
๐งฌ Genetic Analysis
๐ Matching experts to specific tasks
๐ Resource Allocation by Research Phase:
๐ Data Analysis
๐งช Experimental Design
๐ฌ Clinical Trials
๐ Treatment Development
Background: One way to treat liver cancer is to deliver chemotherapy drugs...
Status
Recruiting
Location
National Institutes of Health Clinical Center
Start Date
2022-10-24
Trial ID
NCT05286814
Treatments Being Tested
Combination approaches will almost certainly be required to generate durabl...
Status
Completed
Location
Zuckerberg San Francisco General Hospital, University of California San Francisco
Start Date
2020-08-01
Trial ID
NCT04357821
Treatments Being Tested
STA-5326 is an oral experimental drug that has been shown to block the rele...
Status
Completed
Location
Nih/Niaid
Start Date
2005-11
Trial ID
NCT00234741
Treatments Being Tested
RATIONALE: Interleukin-12 may kill tumor cells by stopping blood flow to th...
Status
Unknown
Location
Beth Israel Deaconess Medical Center
Start Date
1998-06
Trial ID
NCT00003412
Treatments Being Tested
Phase I trial to study the effectiveness of interleukin-12, paclitaxel, and...
Status
Completed
Location
Ohio State University Medical Center
Start Date
2001-11
Trial ID
NCT00028535
Treatments Being Tested
Rheumatoid Arthritis (RA) is a systemic autoimmune disease characterized by...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2024-09
Trial ID
NCT06558305
Treatments Being Tested
Background: Fewer than 10 percent of people with pancreas cancer can have ...
Status
Terminated
Location
National Institutes of Health Clinical Center
Start Date
2021-06-15
Trial ID
NCT04327986
This is an open-label, single-arm, dose-escalation, and dose-expansion clin...
Status
Recruiting
Location
Cancer Hospital Chinese Academy of Medical Sciences
Start Date
2023-09-28
Trial ID
NCT06088004
Treatments Being Tested
This is a Phase 1 open-label study to evaluate the safety, tolerability, an...
Status
Enrolling By Invitation
Location
The First Affiliated Hospital of China Medical Univeristy
Start Date
2024-05-07
Trial ID
NCT06215846
Treatments Being Tested
This is a Phase 1 open label, first in human study of C5252 monotherapy des...
Status
Unknown
Location
Huntsman Cancer Institute
Start Date
2023-03-15
Trial ID
NCT05095441
Treatments Being Tested